Novavax Shares Shoot Up Over 50% Amid Promising Trial Developments
Biotech company Novavax (NASDAQ:NVAX) is enjoying a share rise of 59.40% as of 4:00 PM EST today on the heels of announcing encouraging results in an immunization study. This brings their share value up from ... [Read]
DPW Holdings Sees Upswing of 55% in Stock After Month-Long Decline
DPW Holdings Inc. (NYSE:DPW), a diversified holding company engaged in, among other ventures, the design, manufacture, and sale of switching power supplies and converters, is currently experiencing a recovery in its stock from the recent ... [Read]
The Undervalued SeaChange Is Set To Soar
SeaChange International (NASDAQ:SEAC) is a small cap software application company. Its innovative products and strong financial numbers are impressing investors over the last couple of months. In the latest quarter, the company has substantially beaten ... [Read]
Kodak’s Partners With WENN Digital
Eastman Kodak Co. (NYSE:KODK) share price surged as much as 281% in the last two days alone, driven by the company’s announcement of launching its own form of blockchain technology. After the yesterday rally, KODK ... [Read]
CounterPath Stock Soars and More Upside is Ahead
CounterPath Corporation (NASDAQ:CPAH) stunned investors with massive gains of above 114% in the last month alone, thanks to analysts upgrades and strong future fundamentals. The company’s financial numbers are also impressing and boosting investor’s sentiments. ... [Read]
Akers Biosciences stock soaring – but why?
It’s pharma fever on the stock market today as the likes of Diffusion Pharmaceuticals (NASDAQ:DFFN) and most notably Pain Therapeutics (NASDAQ:PTIE) have seen stock climb by 42.98% and 114.22% respectively. These heady rises come amid ... [Read]
More Upside is Ahead for Spectrum Pharmaceutical Stock
Spectrum Pharmaceuticals Inc (NASDAQ:SPPI) has generated substantial share price appreciation in the last twelve months, due to its strategy of developing drugs in Hematology and Oncology. It currently offers six oncology and hematology drugs, and ... [Read]
Axsome Therapeutics Shares Drop Following ‘Disappointing’ Drug Trial Outcome
It’s a gray morning for Axsome Therapeutics. Shares in the biopharmaceutical company have fallen by -36.94%, bringing the last price to 3.50 as of 2:38 PM EST. The sink comes amid reports that their trial ... [Read]
Diffusion Pharmaceuticals Presents TSC Candidate at Biotech Conference, Stock Climbs 35%
Diffusion Pharmaceuticals Inc. (NASDAQCM:DFFN) has experienced a stock increase of 35% today on the Nasdaq Capital Market. At the time of writing, the stock has moved $0.43, from the previous closing price of $1.21 to ... [Read]
Penny Stock Picks | January 9
Newstrike Resources Ltd. (TSX-V:HIP) On Tuesday, Newstrike’s wholly owned subsidiary and licensed producer, Up Cannabis Inc., received site plan approval from the town of Lincoln, Ontario, for its automated greenhouse facility in the Niagara region. ... [Read]